Institute of Child Health & Department of Paediatrics, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Department of Paediatric Surgery, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Pan Afr Med J. 2021 Aug 6;39(Suppl 1):9. doi: 10.11604/pamj.supp.2021.39.1.20811. eCollection 2021.
intussusception is the invagination of a segment of the bowel into a distal segment. It occurs predominantly in infants worldwide. Following documentation of increased incidence after introduction of the first rotavirus vaccine (Rotashield, Wyeth-Lederle), it has become a standard recommendation to maintain surveillance for intussusception as newer rotavirus vaccines are introduced into EPI. Nigeria plans to introduce rotavirus vaccine in 2020. Pre-vaccine introduction surveillance will serve as a baseline to understand the epidemiology of intussusception in Nigeria.
from 2013 to 2017, prospective enrolment of under five children with intussusception was done following the WHO protocol and using the WHO case report form. Only children who met the Pan American Health Organization/World Health Organization (PAHO/WHO) protocol case definition for intussusception were enrolled. These children were monitored until discharge or death. Clinical features and outcome were recorded in the case report form.
a total of 63 cases were enrolled, with age range of 3 to 42 months (median: 6 months, IQR: 5-9 months). Majority were within 4-6 months and 96% were < 12 months old. There were 41 males and 22 females (male to female ratio of 1.9:1). Duration of symptoms before presentation ranged from 2 hours to 15 days (median: 72 hours). Fifty-seven patients had abdominal ultrasound and 52 patients (83%) had surgery. Case fatality rate was 9% and duration of hospitalization ranged from 1 to 30 days (median 10 days, IQR 8-15 days).
intussusception occurred most commonly in infants but well beyond the proposed age for rotavirus vaccination in the population studied. Late presentation and surgical intervention were common. This data provides a good baseline description of the epidemiology of intussusception.
肠套叠是肠段的嵌入性套叠。它主要发生在全球的婴儿中。在首次轮状病毒疫苗(Rotashield,惠氏-莱德雷尔)引入后,发病率增加得到记录后,随着新型轮状病毒疫苗被引入扩大免疫规划,对肠套叠进行监测已成为标准建议。尼日利亚计划于 2020 年引入轮状病毒疫苗。疫苗引入前的监测将作为了解尼日利亚肠套叠流行病学的基线。
2013 年至 2017 年,按照世界卫生组织方案并使用世界卫生组织病例报告表,前瞻性纳入患有肠套叠的五岁以下儿童。仅纳入符合泛美卫生组织/世界卫生组织(PAHO/WHO)肠套叠方案病例定义的儿童。这些儿童一直被监测到出院或死亡。病例报告表记录了临床特征和结局。
共纳入 63 例病例,年龄范围为 3 至 42 个月(中位数:6 个月,IQR:5-9 个月)。大多数在 4-6 个月之间,96%的患儿年龄小于 12 个月。男 41 例,女 22 例(男女比为 1.9:1)。就诊前症状持续时间为 2 小时至 15 天(中位数:72 小时)。57 例患儿行腹部超声检查,52 例患儿(83%)接受手术。病死率为 9%,住院时间为 1 至 30 天(中位数 10 天,IQR 8-15 天)。
肠套叠最常见于婴儿,但远超出研究人群中轮状病毒疫苗接种的建议年龄。就诊时间晚和手术干预很常见。该数据为肠套叠的流行病学提供了良好的基线描述。